The Art of
Licensing
The Art of
Development
The Art of
Access
The Art of
Manufacturing
The Art of
Partnership
Home > The Art of Licensing > Our locations > USA
United States of America

 USA400-2.jpg
Helsinn Therapeutics (U.S.), Inc. New Jersey.

In 2009 Helsinn acquired the US biotech company Sapphire Therapeutics Inc., to establish the US-based R&D and commercial operation: Helsinn Therapeutics (U.S.), Inc., located in Bridgewater, New Jersey. This business venture has expanded Helsinn’s pipeline of products in existing focus therapeutic areas. Furthermore, the Helsinn Group will be in a position to operate directly on the US market by 2012 with a direct sales structure.

 
Home
Legal Statement
News
Contacts
Sitemap
Document Central
Jobs
Helsinn′s Board of Directors and Top Management
Links
Printer Friendly
Copyright © Helsinn Group - Legal Statement
Last Update: 08.04.2014
Free access to Helsinn newsletter
Subscribe  or Unsubscribe
About Helsinn Our Products Our Partners